TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Prevalence of insulin resistance (IR) in obese patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Early cardiovascular abnormalities in obese asymptomatic patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Volumetric outcome assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of detection of pancreatic abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Physical Activity Enjoyment Scale (S-PACES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Radiation induced pneumonitis rates
Endpoint domain: Adverse events/effects
Primary endpoint: First aid knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percent of Colonic Polyps Visible Contrast
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Interference Level of Detrimental Effects on Visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Subjects With Polyps Visualized
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Serum Deosxysphingolipid Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of treatment modules completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of self-monitoring compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of skills utilization
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual search behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of intraoperative ICG fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form Health Survey (SF-36) - Cohort B
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 5-Dimension Health Questionnaire 5 Level (EQ-5D-5L) - Cohort B
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Absence of endometrial cancer
Endpoint domain: Mortality/survival
Primary endpoint: Neck Disability Index (NDI) scoring
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self-perceived barriers to physical activity
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Decrease of problematic substance use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients with good conditions of comfort during DISE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first severe cardiac or COPD event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intra-operative Internal Thoracic Artery Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bronchial Asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Chronic rhinosinusitis with nasal polyps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Chronic Spontaneous Urticaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Eosinophilic Esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Composite of death and duration of kidney replacement therapy
Endpoint domain: Mortality/survival
Primary endpoint: Geometric Mean Ratio (GMR) of Omicron BA.4/5 mRNA-1283.222 Over the Omicron BA.4/5 mRNA-1273.222
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroresponse Rate (SRR) Difference of Omicron BA.4/5 Between mRNA-1283.222 and mRNA-1273.222
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: rVE of mRNA-1283 and mRNA-1273 (Variant Formulations) to Prevent the First Event of COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: 48h ambulatory systolic blood pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of life by using Oswestry Disability Index (OID)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain (average weekly)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enjoyment of Life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: General Activity (PEG) Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of births that take place in a health facility
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of women that attended prenatal care during pregnancy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Child survival
Endpoint domain: Mortality/survival
Primary endpoint: DFU Infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Amputations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients with an excellent outcome (mRS score 0-1)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Composite of delirium and non-delirium complications within 7 days after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence-free survival after surgery
Endpoint domain: Mortality/survival
Primary endpoint: patient quality of life changes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Melatonin levels for circadian timing assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Melatonin levels for hormone response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Integrity of anal sphincter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Defects on anal canal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Amsterdam Preoperative Anxiety and Information Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Biceps femoris long head fascicle length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Efficacy of WSD0922-FU
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Upper chest expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower chest expansion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fetal liver ultrasound texture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infertility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving HBsAg and HBV DNA lower than LLOQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Discharge Rate of Brachialis Biceps Motor Units
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Effectiveness of surgical treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of surgical treatments
Endpoint domain: Adverse events/effects
Primary endpoint: pulmonary toxicity of grade ≥2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pancreatic Beta-Cell Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximal Interincisal Mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time between venipuncture and TGA result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of time spent depression free
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Grade 2 or higher post-operative wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of treatment-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Surface Electromyography-maximum voluntary isometric contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surface Electromyography-muscles' normal functional activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crohn's Disease Activity Index (CDAI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUVr
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of CVC Tip Colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in average weekly frequency of cluster headache attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause mortality at 30 days post-TAVI procedure
Endpoint domain: Mortality/survival
Primary endpoint: Moderate or greater paravalvular leak at 30 days post-TAVI procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Range of Temporo mandibular Movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical range of movement (CROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of dendritic cells producing IL-23
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 2-year cumulative local regional progression rate (LRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of enrolled participants who complete at least two intervention visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Canadian Occupational Performance Measurement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Worry and Anxiety Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intolerance of Uncertainty Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Concentration of HbA1C (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of self-monitored blood glucose readings within the 70-180 mg/dl range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Hyperglycemic Events
Endpoint domain: Adverse events/effects
Primary endpoint: Count of resident presenting a heart failure decompensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feasibility (Adherence)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Detrusor Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voiding Flow Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary systemic thromboembolism (STE)/stroke
Endpoint domain: Mortality/survival
Primary endpoint: Recurrent bleeding requiring blood transfusion or hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Quantity of NAD(P)(H)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quantity of ox-NAD(P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quantity of PYR-ribosides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quantity of PYR-nucleotides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to reach target INR range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Depression Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Goodman Baron score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaporization efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical function - chair stands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical function - 6 minute walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease-free Survival (DFS) in the PD-L1 ≥1% Population
Endpoint domain: Mortality/survival
Primary endpoint: Disease-free Survival (DFS) in the ITT Population
Endpoint domain: Mortality/survival
Primary endpoint: P selectin marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Binocular uncorrected distance visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hepatitis C Virus (HCV) knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Colorectal Cancer (CRC) knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hepatitis C Virus Screening Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colorectal Cancer Screening Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proton treatment dose overlay accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event-free survival by tumor heterogeneity
Endpoint domain: Mortality/survival
Primary endpoint: Event-free survival by DNA damage response
Endpoint domain: Mortality/survival
Primary endpoint: Event-free survival by tumor DNA alterations
Endpoint domain: Mortality/survival
Primary endpoint: Change of knee range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incident rate of invasive breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients with MINS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of internet addiction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of internet gaming disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction Ratio of Lambda Free Light Chains (λ FLC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction Ratio of Beta-2 Microglobulin (β2-MG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: requirement of vasopressor or intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Suicidal Ideation/Propensity using Beck Scale for Suicide Ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Suicidal Ideation/Propensity using Concise Health Risk Tracking Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Daily Rhythm using Social Rhythm Metric
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Daily Rhythms using Brief Social Rhythm Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Daily Rhythms using Pittsburgh Sleep Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Computer Vision Syndrome-Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma levels of PPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants diagnosed with clinical chorioamnionitis or postpartum endometritis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants diagnosed with sepsis
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who experience death
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Cesarean Sections Among Participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cerebral blood volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Vascular oxygenation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Percentage of respondents at day 8
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Student's knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Student's performance scores
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Student's motivation scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: irAEs rate
Endpoint domain: Adverse events/effects
Primary endpoint: Medication optimization score at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Peak knee extension power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: post-traumatic neuroinflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inhospital Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Indexed Left Ventricular Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feasibility of Psilocybin-Assisted Therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of Psilocybin-Assisted Therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in subjects' cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes brain MRI parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CR/CRi Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expressive aphasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: motor activity right hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity Level (International Physical Activity Questionnaire for Adolescents)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity level (accelerometry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Area of Treatment Sites Autografted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Drug cravings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-efficiency of antegrade wiring strategy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: overall response rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to complete each setup
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of technical issues
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of prenatal appointments attended
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of postpartum appointments attended
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of eligible target population who consent to participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: DECORUM Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Terminal Hair Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Vellus Hair Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Hair Counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake in kcal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinalysis for an alcohol metabolite (EtG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinalysis for cotinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinalysis for cannabis metabolite (THC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anticoagulation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mutuality Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Strength in the adductors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secondary implant stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: weight changes by kilograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of Tumor necrotizing factor alfa in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Level of high sensitive CRP in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Regional activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: type of hemostatic blood products transfused
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes